NIH Common Fund Data Ecosystem: LINCS (CFDE-LINCS) FAIR Rubric

A rubric for evaluating the FAIRness of LINCS Resource

Tags: nihcommonfund

URL(s):

View Associations

Rubric Assessments (33)


Assessment Metrics Date
Target Project   Contact information is provided for the creator(s) of the dataset. Globally unique identifier Machine-readable metadata Standardized metadata Resource identifier in metadata Open, Free, Standardized Access protocol Digital resource license Metadata license The institution that created this dataset is available A biological assay is present and resolvable in CFDE-specified ontology (OBI) A relevant anatomical part is present and resolvable in the UBERON Ontology A relevant disease is present and resolvable in the MONDO Ontology A relevant file type is present and resolvable in the EDAM Ontology A relevant taxonomy is present and resolvable in the NCBITaxon Ontology A relevant cell line is present and resolvable in the Cellosaurus Ontology A landing page exists and is accessible Relevant Drug or Small Molecule terms are resolvable in PubChem Relevant Gene IDs are resolvable as NCBI Entrez Genes
L1000 Dataset -small molecule, CRISPR perturbagens- LINCS Phase 2 (December 2015) FAIRshake Testing
                                    Aug 9, 2021
LINCS L1000 Chemical Perturbations (2021) LINCS: Assessment of NIH Common Fund Resources with C2M2
  no (0.00) yes (0.98)   yes (1.00) yesbut (0.75) no (0.00)   yes (1.00) nobut (0.25) yes (0.99) yes (0.87) no (0.00) no (0.00) maybe (0.47) yes (1.00)     Sep 20, 2021
LINCS L1000 shRNA Perturbations (2021) LINCS: Assessment of NIH Common Fund Resources with C2M2
  no (0.00) yes (1.00)   yes (1.00) yesbut (0.75) no (0.00)   yes (1.00) nobut (0.25) yes (1.00) yes (0.89) no (0.00) no (0.00) maybe (0.49) yes (1.00)     Sep 20, 2021
LINCS L1000 CRISPR Perturbations (2021) LINCS: Assessment of NIH Common Fund Resources with C2M2
  no (0.00) yes (1.00)   yes (1.00) yesbut (0.75) no (0.00)   yes (1.00) nobut (0.25) yes (1.00) yes (1.00) no (0.00) no (0.00) maybe (0.50) yes (1.00)     Sep 20, 2021
LINCS L1000 Antibody Perturbations (2021) LINCS: Assessment of NIH Common Fund Resources with C2M2
  no (0.00) yes (1.00)   yes (1.00) yesbut (0.75) no (0.00)   yes (1.00) nobut (0.25) yes (1.00) yes (1.00) no (0.00) no (0.00) maybe (0.50) yes (1.00)     Sep 20, 2021
LINCS L1000 siRNA Perturbations (2021) LINCS: Assessment of NIH Common Fund Resources with C2M2
  no (0.00) yes (1.00)   yes (1.00) yesbut (0.75) no (0.00)   yes (1.00) nobut (0.25) yes (1.00) yes (1.00) no (0.00) no (0.00) maybe (0.50) yes (1.00)     Sep 20, 2021
LINCS L1000 Ligand Perturbations (2021) LINCS: Assessment of NIH Common Fund Resources with C2M2
  no (0.00) yes (1.00)   yes (1.00) yesbut (0.75) no (0.00)   yes (1.00) nobut (0.25) yes (1.00) yes (0.94) no (0.00) no (0.00) maybe (0.50) yes (1.00)     Sep 20, 2021
LINCS L1000 Overexpression Perturbations (2021) LINCS: Assessment of NIH Common Fund Resources with C2M2
  no (0.00) yes (1.00)   yes (1.00) yesbut (0.75) no (0.00)   yes (1.00) nobut (0.25) yes (1.00) yes (0.83) no (0.00) no (0.00) maybe (0.49) yes (1.00)     Sep 20, 2021